Life Science & Instruments

Europe has remained the second largest regional market for analytical and life science instrumentation (after North America) for many years, with steady growth in the low- to mid-single-digit range. Generally speaking, the western part of the continent is made up of highly developed, mature instrument markets, while the eastern part holds strong growth potential. The…

Cell and gene therapy (CGT) is a rapidly evolving field producing powerful new treatments for cancers and genetic diseases, and expanding into autoimmune disease, cardiovascular disease, musculoskeletal disease, and many others. The CGT field has generated great interest and hope among researchers, patient groups, and regulators, which has led to huge investments in R&D. Globally,…

Contract manufacturing is becoming increasingly vital in the pharmaceutical industry, particularly in cell and gene therapy due to the high demand for these innovative products. Kalorama Information’s report, Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs), provides comprehensive insights into this dynamic market.

Report Highlights:

• Biopharmaceutical Contract Manufacturing Market: In-depth analysis of…

This report provides detailed data on every major life science and analytical instrument technology in the industry, enabling you and your staff to make accurate evaluations and informed decisions. Numerous vendors, distributors and investors will reference this report over the coming years as the most comprehensive and accurate source of information on the instrument industry…

The global academic market for analytical and life science instrumentation is enormous. Covering 17% of the $67 billion industry, it is the largest individual end market, encompassing university research labs, core labs, non-profit research institutes, and university clinical research. A bastion of basic research, academia is at the frontier of scientific discovery itself. For today’s…

Outsourcing drug discovery represents the initial phase of the drug development process. By outsourcing segments of their drug discovery programs, pharmaceutical and biotechnology companies have discovered a cost-effective strategy that enhances hit-to-lead conversion and early identification of ineffective compounds. Outsourcing accelerates the drug discovery process, transforming the industry from low-end research services to high-value, sophisticated…

What is the size of the cell and gene therapy market? According to Cell Therapy and Gene Therapy Markets, 2020 from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3.9 billion, with most of the market focused on the treatment of cancer. This exciting period in the…

Non-alcoholic steatohepatitis (NASH) is a serious liver disease characterized by inflammation and liver cell damage, which can lead to cirrhosis. Despite the absence of approved medications specifically for NASH, there are nearly 80 drug candidates in development. Kalorama Information’s report, NASH Drug Pipeline and Market Overview, provides an in-depth analysis of these drug candidates, including…